# Mendelian randomisation with proxy exposures
Code from the manuscript '[Mendelian randomisation with proxy exposures: challenges and opportunities](https://doi.org/10.1101/2024.10.21.24315891)'

## Analysis code
* [Metabolite data QC and normalisation](https://github.com/AlasooLab/MR_with_proxy_exposures/blob/main/code/ukbb_300k_QC.R)
* GWAS analysis and fine mapping: [reGSusie workflow](https://github.com/AlasooLab/reGSusie)
* [MR analysis: glycolysis pathway vs RBC count](https://github.com/AlasooLab/MR_with_proxy_exposures/blob/main/code/Fig2_pyruvate.R)
* [HAL locus colocalisation](https://github.com/AlasooLab/MR_with_proxy_exposures/blob/main/code/Fig3_HAL_coloc.R)
* [MR analysis: HAL activity vs vitamin D](https://github.com/AlasooLab/MR_with_proxy_exposures/blob/main/code/Fig5_HAL_MR.R)
* [HAL eQTL tissue specificity](https://github.com/AlasooLab/MR_with_proxy_exposures/blob/main/code/FigS3_HAL_volcano_plot.R)

## Data
* [GWAS summary statistics for 56 metabolic traits](https://doi.org/10.5281/zenodo.13821209)
* [Fine mapping results for 56 metabolic traits](https://doi.org/10.5281/zenodo.13821038)
* [Harmonised effect sizes and standard errors for 22 fine mapped missense varaiants associated wth histidine and pyruvate](https://github.com/AlasooLab/MR_with_proxy_exposures/blob/main/data/glucose_pyruvate_histidine_missense.tsv)
